6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
9m ago	FatPipe Unveils VeloCloud Replacement Program with Price Match, 15% Discounts and 10% Partner Rebates
35m ago	Angle Advisors announces Shift Transit has been recapitalized by Main Street Capital Corporation
35m ago	Century Complete Announces New Homes Coming Soon to Fleming Island, FL
36m ago	Sprott Physical Copper Trust Announces Preliminary Proxy Results for Unitholder Meeting and Anticipated Listing Date on the NYSE Arca
36m ago	Tambourine & Hyatt Launch Hyatt Wedding Guide to Revolutionize Digital Wedding Planning

About

Kura Oncology Inc (NASDAQ:KURA) — investor relations, events, news, and company updates on 6ix.

Latest News

Kyowa Kirin and Kura Oncology Initiate Japanese Phase 2 Registration-Directed Trial of Ziftomenib in R/R NPM1-m AML

Kura Oncology Reports Darlifarnib Plus Cabozantinib Demonstrates Robust Activity in Patients With Clear Cell Renal Cell Carcinoma Previously Treated With Cabozantinib

Kura Oncology to Present Darlifarnib Plus Cabozantinib Data in Patients with Clear Cell Renal Cell Carcinoma Previously Treated with Cabozantinib at IKCS Europe 2026

Kura Oncology Reports Fourth Quarter and Full Year 2025 Financial Results

Kura Oncology to Report Fourth Quarter and Full Year 2025 Financial Results

Financials

Revenue

$67.48 M

Market Cap

$760.52 M

EPS

-3.18

Community Chat

Ask AI